NSPR logo

NSPR
InspireMD Inc

34,482
Mkt Cap
$66.95M
Volume
23,295.00
52W High
$3.80
52W Low
$1.51
PE Ratio
-1.94
NSPR Fundamentals
Price
$1.63
Prev Close
$1.58
Open
$1.65
50D MA
$1.83
Beta
0.41
Avg. Volume
35,362.30
EPS (Annual)
-$0.7633
P/B
1.07
Rev/Employee
$81,500.00
Loading...
Loading...
News
all
press releases
InspireMD (NYSE:NSPR) Stock Price Down 1.8% - Should You Sell?
InspireMD (NYSE:NSPR) Trading Down 1.8% - Time to Sell...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
InspireMD (NYSE:NSPR) Shares Up 2% - Should You Buy?
InspireMD (NYSE:NSPR) Trading 2% Higher - Here's Why...
MarketBeat·2mo ago
News Placeholder
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of 0.00% and +31.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates
Hologic (HOLX) delivered earnings and revenue surprises of +2.73% and +1.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of +20.60% and +3.92%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains?
CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·7mo ago
News Placeholder
InspireMD Launches CGuard Prime Carotid Stent System in the U.S.
NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.
Zacks·7mo ago
News Placeholder
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic
The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets.
Stocktwits·9mo ago
<
...
1
>

Latest NSPR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.